Researchers at the University of Pittsburgh and collaborating MS centers are seeking adults with and
without a diagnosis of multiple sclerosis or other neuroinflammatory disease for a one-time online survey study to help understand the lasting impact of COVID-19.
People who have multiple sclerosis (MS) or other neuroinflammatory diseases may have different experiences and concerns related to COVID-19 infection, COVID-19 vaccines, and Post-Acute Sequelae of SARS-CoV-2 (PASC of COVID-19, or long COVID) when compared to people without these conditions. The purpose of this survey study is to better understand the prevalence and predictors of PASC in people with and without MS (or a related disorder such as neuromyelitis optica spectrum disorder [NMOSD] or myelin oligodendrocyte glycoprotein antibody-associated disorder [MOGAD]). Researchers hope their findings lead to a better understanding of COVID-19 in general and improve care for our patients.
To qualify, you:
- Are at least 18 years old
- May or may not have had a diagnosis of COVID-19
- May or may not have a diagnosis of multiple sclerosis or another neuroinflammatory disease (e.g., NMOSD, MOGAD)
Participation in the study involves a one-time online survey that will take approximately 15-30 minutes. To read more about the survey or to sign up, please click the link below.
If you have any questions, please contact the research team by email (firstname.lastname@example.org
) or phone (412-254-4883).